The function of sildenafil on female sexual pathways: A double-blind, cross-over, placebo-controlled study

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 110, Issue 2, 2003, Pages 201-206

  Caruso, Salvatore ^a   Intelisano, Giorgia ^a   Farina, Marco ^a   Di Mari, Lucia ^a   Agnello, Carmela ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Efficacy and safety of sildenafil; Female sexual activity; Female sexual dysfunction; Healthy pre menopausal women

Indexed keywords

SILDENAFIL;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG UTILIZATION; EXPERIENCE; FEMALE; FOLLOW UP; HEADACHE; HEALTH CENTER; HUMAN; HUMAN EXPERIMENT; ITALY; NAUSEA; NORMAL HUMAN; ORGASM; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; RATING SCALE; SEXUAL AROUSAL; SEXUAL FUNCTION; SEXUALITY; STATISTICAL ANALYSIS; STUDENT T TEST; VISUAL DISORDER;

EID: 0041325165     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(03)00118-0     Document Type: Article

References (25)

1. Laumann E.O., Paik A., Rosen R.C. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 10(281(6)):1999;537.
2. Shabsigh R. Prevalence of and recent developments in female sexual dysfunction. Curr. Psychiatry Rep. 3:2001;188-194.
3. Davis A.R. Recent advances in female sexual dysfunction. Curr. Psychiatry Rep. 2:2000;211-214.
4. Basson R. Female sexual response: the role of drugs in the management of sexual dysfunction. Obstet. Gynecol. 98:2001;350-353.
5. Leiblum S.R. Definition and classification of female sexual disorders. Int. J. Impot. Res. 10(Suppl. 2):1998;S104.
6. Pfaus J.G. Neurobiology of sexual behaviour. Curr. Opin. Neurobiol. 9:1999;751-758.
7. Berman J.R., Adhikari S.P., Goldstein I. Anatomy and physiology of female sexual function and dysfunction: classification. Eur. Urol. 38:2000;20-29.
8. Min K., O'Connell L., Munarriz R., Huang Y.H., Choi S., Kim N.et al. Experimental models for the investigation of female sexual function and dysfunction. Int. J. Impot. Res. 13:2001;151-156.
9. Sax D.S., Berman J.R., Goldstein I. Female neurogenic sexual dysfunction secondary to clitoral neuropathy. J. Sex Marital Ther. 27:2001;599-602.
10. Baskin I.S., Erol A., Li Y.W., Liu W.H., Kurzrock E., Cunha G.R. Anatomical studies of the human clitoris. J. Urol. 162:1999;1015-1020.
11. Berman J.R., Berman L.A., Lin H.et al. Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder. J. Sex Marital Ther. 27:2001;411-420.
12. Perelman M.A. The impact of the new sexual pharmaceuticals on sex therapy. Curr. Psychiatry Rep. 3:2001;195-201.
13. Moreland R.B., Goldstein I., Traish A. Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernousum smooth muscle cells. Life Sci. 62:1998;309-318.
14. Park K., Moreland R.B., Goldstein I., Atala A., Traish A. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernousum smooth muscle. Biochem. Biophys. Res. Commun. 249:1998;612-617.
15. Caruso S., Intelisano G., Lupo L., Agnello C. Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study. Br. J. Obstet. Gynaecol. 108:2001;623-628.
16. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. Washington DC: American Psychiatric Association; 1994.
17. World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems. Geneva: WHO; 1992.
18. McCoy N.L., Matyas J.R. Oral contraceptives and sexuality in university women. Arch. Sex Behav. 23:1996;73-79.
19. Dennerstein L., Duldey E.C., Hopper J.L., Burger H. Sexuality. Maturitas. 26:1997;83-93.
20. Rosen R.C. Measurement of male and female sexual dysfunction. Curr. Psychiatry Rep. 3:2001;182-187.
21. Tuiten A., Van Honk J., Koppeschaar H., Bernaards C., Thijssen J., Verbaten R. Time course of effects of testosterone administration on sexual arousal in women. Arch. Gen. Psychiatry. 57:2000;149-153.
22. Modell J.G., May R.S., Katholi C.R. Effect of bupropion-SR on orgasmic dysfunction in nondepressed subjects: a pilot study. J. Sex Marital Ther. 26:2001;231-240.
23. Segraves R.T., Croft H., Kavoussi R. Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women. J. Sex Marital Ther. 27:2001;303-316.
24. Michelson D., Bancroft J., Targum S., Kim Y., Tepner R. Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. Am. J. Psychiatry. 157:2000;239-243.
25. Meston C.M., Frohlich P.F. Update on female sexual function. Curr. Opin. Urol. 11:2001;603-609.